Susan W Lee

Suggest Changes
Learn More
PURPOSE Carfilzomib is an irreversible inhibitor of the constitutive proteasome and immunoproteasome. This phase I study evaluated the maximum-tolerated dose (MTD), pharmacokinetics, and(More)